Optimization of Methylphenidate Extended-Release Chewable Tablet Dose in Children with ADHD: Open-Label Dose Optimization in a Laboratory Classroom Study

Objective: To examine methylphenidate extended-release chewable tablets (MPH ERCT) dose patterns, attention-deficit/hyperactivity disorder (ADHD) symptom scores, and safety during the 6-week, open-label (OL) dose-optimization period of a phase 3, laboratory classroom study. Methods: Boys and girls (...

Descripción completa

Detalles Bibliográficos
Autores principales: Wigal, Sharon B., Childress, Ann, Berry, Sally A., Belden, Heidi W., Chappell, Phillip, Wajsbrot, Dalia B., Nagraj, Praneeta, Abbas, Richat, Palumbo, Donna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994665/
https://www.ncbi.nlm.nih.gov/pubmed/29641237
http://dx.doi.org/10.1089/cap.2017.0138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994665/
https://www.ncbi.nlm.nih.gov/pubmed/29641237
http://dx.doi.org/10.1089/cap.2017.0138

Ejemplares similares